Skip to main content


The Challenges of Sarcoma

The first article has now been published in this thematic series exploring the challenges clinicians face in early recognition and diagnosis of sarcomas. We're delighted to produce this series in collaboration with the Clinical Sarcoma Research journal, comprising of review articles written by leading global experts in the field.


  1. Authors: Zachary Burningham, Mia Hashibe, Logan Spector and Joshua D Schiffman

    Content type: Review

Aims and scope

Clinical Sarcoma Research considers for publication articles related to research on sarcomas, including both soft tissue and bone. The journal publishes original articles and review articles on the diagnosis and treatment of sarcomas along with new insights in sarcoma research, which may be of immediate or future interest for diagnosis and treatment. The journal also considers negative results, especially those from studies on new agents, as it is vital for the medical community to learn whether new agents have been proven effective or ineffective within subtypes of sarcomas. The journal also aims to offer a forum for active discussion on topics of major interest for the sarcoma community, which may be related to both research results and methodological topics.

Call for papers: Translational oncology

We are pleased to announce that a number of BioMed Central journals have come together to create a new cross-journal series on translational oncology.

The series is now accepting submissions of research articles that provide important developments in cancer research. Preclinical studies should provide a significant advance in knowledge, and have clear potential for strong clinical impact.

More information

Soft Tissue Sarcoma Webcast

New Content Item

Chair: Robin Jones (The Royal Marsden Hospital, London, UK)
Bernd Kasper  (University Medical Centre Mannheim, Mannheim, Germany)
Vasilios Karavasilis (University College London Hospital, London, UK)

    New Content Item

This webcast provides the latest information on the current and emerging treatment formats which could improve outcomes for patients with STS, the standards of care for patients with STS and how these are best met within the context of a multidisciplinary team. 

Click here to go to the webcast page         

Learning objectives:
After viewing the webcast, Soft tissue sarcoma: what is best practice? You should be able to:

  •  Assess the new treatment and diagnosis paradigms for A-STS and explain how to best apply them to their daily practice.
  • Explain the current best practice for providing treatment STS within the context of the multidisciplinary team.

Meet the Editors-in-Chief

Dr Paolo G Casali is head of the Adult Mesenchymal Tumour Medical Oncology Unit, Istituto Nazionale Tumori, Milan, Italy. He serves as Secretary of the Ethics Committee of his institution. His research focuses on rare tumors, especially adult sarcomas, including gastrointestinal stromal tumors (GIST), and uncommon histological types. He is the Secretary of the Italian Sarcoma Group, and is a member of the EORTC Soft Tissue & Bone Sarcoma Group. He chairs the Italian Network on Rare Tumors, a collaborative effort among Italian cancer centers, which endeavours to exploit distant patient sharing in order to improve quality of care and diminish health migration for rare solid cancers. He acts as an Editor of START, an Italian-based, European state-of-the-art instrument on cancer treatment. He is a member of the Executive Board of ESMO as chair of the Public Policy/European Affairs Committee, and is Faculty Coordinator for Sarcoma. He is a member of the Policy Committee of ECCO. He teaches Medical Therapy of Rare Cancers at the Milan University postgraduate school in Oncology. 

Dr. Angelo Paolo Dei Tos is the Director of the Department of Oncology and Director of Anatomic Pathology at the General Hospital in Treviso, Italy, and Contract Professor of Pathology at the University of Padua School of Medicine. He is the Chairman of the Pathology Subcommittee of the Soft Tissue and Bone Group of EORTC, Founder and Past Chairman of the Working Group on Soft Tissue Tumor Pathology of the European Society of Pathology, Past President of the International Society of Bone and Soft Tissue Pathology, panel member for the WHO classification of Bone and Soft Tissue Sarcomas, member of the Board of Directors of the Connective Tissue Oncologic Society, and a faculty member of ESMO. He has authored or co-authored more than 140 peer reviewed scientific papers.

The journal is an integral part of the euroSARC project funded by the European Commission through the 7th Framework Programme under Grant Agreement no. 278742.


Annual Journal Metrics

  • Speed
    63 days to first decision for reviewed manuscripts only
    63 days to first decision for all manuscripts
    100 days from submission to first decision
    34 days from acceptance to publication

    22 Altmetric Mentions